Victory Capital Holdings, Inc. (VCTR): what the price assumes

In the published model solve dated 2026-Q2, anchored at $100.03, Victory Capital Holdings, Inc. (VCTR) is priced for +15.2% earnings growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-07-25.

Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/VCTR

Headline

FieldValue
TickerVCTR
CompanyVictory Capital Holdings, Inc.
Sector / IndustryFinancial Services
Current price$100.03/sh
CompositionInvestment management fees 80% / Fund administration and distribution fees 20%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basisfee-financial
Implied earnings growth15.2%
Price-to-earnings22.7x
Earnings yield4.4%

Solve inputs: computed at a 11.2% cost of equity with 4% terminal growth over a 5-year stage, on a 5-year median GAAP earnings base; each 1pp of cost of equity moves the implied earnings growth ~3.7pp.

Reconcile: at the x-ray's 9.3% required return this reads ~7.2%/yr; the models below use their own rates.

How unusual the bet is: within-range

ReferenceValue
vs own history-0.24σ
cohort percentile (of 51 peers)55
sustained it ~5 years at this level38%
implied end-window share0%

Valuation X-Ray

Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset1.52x5expensive
Earnings2.06x5expensive
Relative1.64x4expensive
Growth0.65x4justifies

Families that justify the price: Growth Families that call it expensive: Asset, Earnings, Relative

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.2%); the inversion above states its own rate.

Per-Model Detail (n=18)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$351.920.28xyesFCF base $0.5B, growth 25% (input: historical growth), terminal g 4.0%, WACC 8.2%, 7yr projection
DCF Exit MultipleGrowth$164.970.61xyesExit EV/EBITDA: 8.3x / 11.3x / 14.3x (bear / base = today's held flat / bull), 7yr
Relative ValuationRelative$87.601.14xyesP/E 12x (static sector reference · 2026-04), scenarios: 9.6x / 12.0x / 14.4x (bear / base = reference held flat / bull), EV/EBITDA N/Ax
Simple DDMGrowthno
Two-Stage DDMGrowth$41.712.40xyesStage 1: 0% for 5yr, Stage 2: 3.5% perpetual
Simple Excess ReturnAsset$65.741.52xyesBV/sh $37.74, ROE (TTM) 16.1%, ke 9.3%
Two-Stage Excess ReturnAsset$85.651.17xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$145.140.69xyesRev $1.5B, growth 30% (input: historical growth; tapered), Terminal P/S: 3.4x / 4.2x / 5.1x (bear / base = today's held flat / bull, cap 12x)
Peter Lynch Fair ValueRelative$53.401.87xyesEPS $4.45, growth 0% (input: historical EPS growth), PEG=44.34 (Overvalued)
Margin TrajectoryGrowthno
Earnings Power ValueEarnings$48.572.06xyesNormalized EBIT (5y avg op income, one-time charges added back) $0.42B × (1−24%) / WACC 8.2% → EPV (no growth)
Residual IncomeAsset$86.981.15xyesBV $37.74 + 5yr PV of (ROE (TTM) 16.1% − Kₑ 9.3%) × BV; BV grows 8.8%/yr
Graham NumberAsset$61.471.63xyes√(22.5 × EPS $4.45 × BVPS $37.74) — Graham's conservative floor
EV/EBITDA RelativeRelativeno
FCF YieldEarnings$58.681.70xyesFCF $421.9M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarnings$54.471.84xyesSBC-adj FCF $0.40B (FCF $0.42B − SBC $0.02B) capitalized at Kₑ
Ben Graham FormulaEarnings$34.472.90xyesEPS $4.45 × (8.5 + 2×0.4%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset$17.185.82xyesBV $37.74 × (ROIC 3.7% / WACC 8.2%)
P/Sales SectorRelative$70.741.41xyesRevenue $1.47B × sector P/S 3.0x
PEG Fair ValueRelative$22.254.50xyesEPS $4.45 × (PEG 1.5 × growth 0.4% (input: historical EPS growth)) → PE 0.6x
Earnings YieldEarnings$48.112.08xyesEPS $4.45 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Economic-Unit Decomposition (Sum Of The Parts)

Only one reportable economic unit is present in the current topology source. Consolidated operating lenses remain available, but there is no multi-unit decomposition.

UnitRoleValuation basisRevenueReported profitValue evidenceStatus
Investment management (whole-company)operatingenterprise1.3B reported-currencywithheldunresolved no unit value

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

FieldValue
Net debt$892.2m
Net debt / NOPAT (after-tax)2.16x
Net debt / operating income (pre-tax)1.64x
Interest coverage8.8x
Share count CAGR (buyback)-3.3%
Burning cashno

Bullet Takeaways

Bull Case

The fear is easy to state, and the company states it first. Its FY2025 annual report acknowledges that "across the investment management industry, passive products have experienced inflows and traditional actively managed products have experienced outflows" and that "our strategies are generally considered active". That is the bear case written by the issuer and filed with the regulator. What is worth testing is whether the numbers underneath confirm the fear or cut against it.

Begin with what happens to a dollar of revenue on the way through. Operating profit ran about $484.4 million on roughly $1.47 billion of trailing revenue, and that conversion rate stands at the top of the listed cohort rather than the bottom: APAM converts 33.3% of revenue into operating profit, SEIC 27.9%, JHG 29.6% and FHI 27.4%. A business supposedly being competed out of existence is keeping a larger share of each fee dollar than most of the managers standing next to it.

Scale is the mechanism. During 2025 the firm "closed on our strategic transaction with Amundi SA ("Amundi") to combine their U.S. operations ("Amundi US") into Victory Capital", and assets under management started 2026 at $313.8 billion against $171.9 billion twelve months earlier. Revenue followed the assets: $1.3 billion for 2025 against $893.5 million for 2024. Running an investment strategy costs roughly the same whether the pool behind it is ten billion dollars or thirty, so in this industry enlarging the pool is the most reliable thing a management team can do, and it does not require being right about markets.

Distribution is the quieter advantage. Eight investment franchises plus a solutions platform offered 187 strategies at the end of 2025, with the solutions platform alone managing $55.8 billion. Breadth of that kind matters because of where it lands: the company states that "We have several products on the research recommended/model portfolios of the top U.S. intermediary platforms." Retail money does not usually choose a fund; a platform's model portfolio chooses it, and being inside those portfolios is the difference between selling and being sold.

Shareholders have been getting paid while this happened. The share count has fallen about 3.3% a year over the four years to March 2026, and operations produced 121.0 million dollars in the March quarter against 81.1 million in the same quarter a year before. The concession the bull owes is real enough: client flows in that quarter were negative. But a firm whose margin, scale and cash generation all point the same way while flows are merely flat is a very different animal from one where all four are sliding together.

Bear Case

Revenue here is a percentage of somebody else's asset prices. The annual report puts it without decoration: investment management fees "are calculated as a contractual percentage of AUM". That one sentence is the entire macro exposure. When equity markets rise the revenue rises with no effort at all, and when they fall it falls with no defence available. Assets reached $342.4 billion as of June 30, 2026 from $313.8 billion at the start of the year, and very little of that increase was taken from a competitor.

Underneath the market's lift, the organic picture is flat at best. Net client flows for the March 2026 quarter were an outflow of 654 million dollars. Against a pool of this size that is a small number, but direction is what matters, because flows are the part of the business management actually controls. The structural drift behind it is the one the company itself names in its risk factors: passive products taking money in while actively managed products let money out, in an industry where its own strategies sit on the active side of that line.

The financing does not flex when markets do. Term loan principal outstanding was 982.5 million dollars at the last annual report, since repriced into 985.0 million dollars of loans maturing on September 23, 2032, bearing interest at SOFR plus a margin of 2.00%. Net debt sits at about 1.84 times operating profit and operating profit covers interest 7.7 times, both perfectly comfortable at current asset levels. The shape changes in a drawdown. Fee revenue falls roughly in line with markets, the interest bill does not fall at all, and a floating margin over SOFR can rise in precisely the conditions where revenue is shrinking.

The balance-sheet defence is thinner than it looks. Book value runs about $36.65 a share, but indefinite-lived intangible assets alone stood at $2,095.8 million at the last annual report, which accounts for most of what that equity is made of. Those intangibles are fund advisory contracts and trade names acquired in transactions. They are real in the sense that they generate fees. They are not real in the sense that they could be sold to plug a hole. And there is an outstanding bill from past dealmaking: contingent payments of up to $320.0 million, capped at $80.0 million a year, are payable to the sellers of one acquired business depending on that business's net revenue.

Which leaves the price and what it requires. At about 22 times earnings, it needs fee earnings to compound at roughly 14.3% a year for five years. The firm has grown at that speed, so the rate is not the objection. The composition is. Revenue went from $893.5 million in 2024 to $1.3 billion in 2025 by combining another firm's business into this one, not by winning mandates. Repeating the pace means either another transaction of similar scale or an organic result that the recent flow numbers do not yet show. Among fee managers growing earnings that fast, only about 40% sustained it for five years. This is not an expensive stock by the standards of the market. It is a stock whose growth has to keep being purchased.

Valuation

A fee business is worth what its fees earn rather than what it owns, so the price here is read against earnings. It works out at about 22 times them, an earnings yield of 4.5%, and the assumption folded inside is fee earnings compounding at roughly 14.3% a year for five years before settling to a slower long-run pace. The base for that calculation is the median of the last five years of reported earnings rather than the most recent single year, which is the right choice for a company that has just changed size.

Measured against its own record, the required pace is unremarkable; the firm has delivered faster. Measured against the industry it is harder work: among fee managers growing earnings at that rate, only about 40% kept it going for five years. The requirement is also more rate-sensitive than a fee business intuitively feels. Add one percentage point to the cost of equity and the growth the price demands moves by about 3.7 points.

The methods split along a clean line. The price stands about 102% above the earnings-power approaches and about 61% above the peer-multiple approaches, while the growth-based approaches land above today's price. Read plainly, that says the price is not defended by what the business earns now. It is defended by what the recent growth rate implies about the next several years, and that growth rate carries a caveat worth stating: the history those methods extend forward includes a transaction rather than only trading.

Against the cohort, the fee margin is the strongest card in the hand. Operating profit of about $484.4 million on roughly $1.47 billion of revenue converts at a rate above JHG at 29.6%, FHI at 27.4% and SEIC at 27.9%, with APAM at 33.3% the closest match. Growth in the same group runs slower and steadier, with APAM at 8.7% and SEIC at 9.4% over the trailing year. The firm's own book value of $36.65 a share is worth putting alongside that, because it is mostly acquired intangibles rather than deployable capital, which is why the asset-based approaches are a poor guide to this particular business in either direction.

Solvency is not stressed, though it is not beside the point either. Net debt is about 1.84 times operating profit, interest is covered 7.7 times, and the share count has come down about 3.3% a year across the four years to March 2026. What no balance sheet can do here is stabilise the revenue line, because that line is a percentage of asset values the firm does not set. That is the reason the earnings-power approaches land where they land.

Catalysts

The next report is close. Second-quarter results are scheduled for August 5, 2026, and the shape of them is partly known already: the company disclosed on July 15, 2026 that assets under management stood at $342.4 billion as of June 30, against $313.8 billion at the start of the year. The line to look for is not the total. It is the split between market appreciation and client flows, since the March quarter carried an outflow of 654 million dollars.

Governance moved in late July. On July 23, 2026 the company announced changes to its board, with Dominique Carrel-Billiard stepping down as a director. Board composition at this firm is worth watching more than at most, because the 2025 combination brought a large outside institution into the shareholder register and the boardroom at the same time.

The sell side moved in the same week and in the same direction. RBC Capital raised its target to $107 from $95 with an Outperform rating on July 23, 2026, and Barclays raised its own to $95 from $85 while keeping an Equal Weight rating on July 16. The gap between those two ratings on nearly the same number is a fair summary of the disagreement described above: one view credits the acquired scale continuing to compound, the other prices the earnings roughly as they stand. Holders are paid $2.00 a share annually while that argument resolves, with the most recent ex-dividend date on June 10, 2026.

Peer Cohorts (Per Segment, With Filing Citations)

Investment management (whole-company) (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

company AUM disclosure, July 15, 2026 · stockanalysis.com earnings calendar, July 2026 · Q1 FY2026 Form 10-Q, accession 0001193125-26-210575 · company announcement, July 23, 2026 · broker actions reported by stockanalysis.com, July 2026 · stockanalysis.com dividend data, July 2026

View the full interactive VCTR report on boothcheck